Dr. Singh is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
675 E Nicollet Blvd
Ste 100
Burnsville, MN 55337Phone+1 952-892-7190Fax+1 952-892-7956
Education & Training
UPMC Medical EducationFellowship, Hematology and Medical Oncology, 2004 - 2007- UPMC Medical EducationResidency, Internal Medicine, 2001 - 2004
Grant Medical CollegeClass of 1999
Certifications & Licensure
MN State Medical License 2007 - 2024
CA State Medical License 2003 - 2021
PA State Medical License 2001 - 2007- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
Publications & Presentations
PubMed
- 114 citationsLong-term outcomes for ibrutinib-rituximab and chemoimmunotherapy in CLL: updated results of the E1912 trial.Tait D Shanafelt, Xin Victoria Wang, Curtis A Hanson, Elisabeth M Paietta, Susan O'Brien
Blood. 2022-07-14 - 124 citationsCarfilzomib or bortezomib in combination with lenalidomide and dexamethasone for patients with newly diagnosed multiple myeloma without intention for immediate autolog...Shaji Kumar, Susanna Jacobus, Adam D. Cohen, Matthias Weiss, Natalie S. Callander
The Lancet. Oncology. 2020-10-01 - 452 citationsIbrutinib–Rituximab or Chemoimmunotherapy for Chronic Lymphocytic LeukemiaTait D. Shanafelt, Xin V. Wang, Neil E. Kay, Curtis A. Hanson, Susan O'Brien
The New England Journal of Medicine. 2019-07-31
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
